Pharynx
Introduction
Organogenesis is the intricate developmental process by which a pool of undifferentiated cells come together to form a functioning organ. Master regulators of organogenesis -so called 'organ identity genes' -act to pattern the organ and ensure that the precise gene regulatory programs are executed in the correct cells in time and space. During development of the Caenorhabditis elegans pharynx (foregut), the pharyngeal master regulator, the PHA-4/FoxA transcription factor, is activated in the embryonic cells that give rise to pharyngeal tissue (Horner et al., 1998; Kalb et al., 1998) . PHA-4 initiates a transcriptional regulatory network that will target all pharyngeal expressed genes, either directly or indirectly (Gaudet and Mango, 2002; Gaudet et al., 2004; Zhong et al., 2010) .
While PHA-4 is required to generate all of the cells of the C. elegans pharynx, it is not clear how this single factor specifies the five different types of pharyngeal cells, which include muscle, epithelial, neuronal, marginal and gland cells. Indeed, promoter analysis of genes expressed in the pharynx has demonstrated that cis-regulatory elements in addition to PHA-4 binding sites are required for expression, suggesting that PHA-4 acts with other factors to specify specific types of cells within the organ. For example, the pharyngeal muscle myosin gene, myo-2, is regulated by the trans-acting factors CEH-22/Nkx, PEB-1/FLYWICH, and DAF-12/NHR in addition to PHA-4 (Ao et al., 2004; Kalb et al., 2002; Okkema and Fire, 1994) . Interestingly, the individual expression patterns of any of these single factor does not mirror the expression of myo-2, and loss of any individual factors (other than PHA-4) does not result in complete loss of myo-2 expression. These findings suggest that the combinatorial sum of PHA-4 and other transcription factors (some of which have yet to be identified) activates muscle-specific expression of myo-2. Similar conclusions were drawn by analysis of other pharyngeal genes. For example, the bHLH transcription factor hlh-6 is regulated by positive elements/factor(s) in linearly related pharyngeal cells, and then a negative element/factor is required to restrict the expression of hlh-6 specifically to the gland cells (Raharjo and Gaudet, 2007; Ghai and Gaudet, 2008) .
We are interested in understanding how gene expression in one particular pharyngeal cell type, the gland cells, is specified. We previously examined the regulation of a subset of gland-expressed genes called the phat (PHAryngeal gland Toxin-related) genes, which encode mucin-like proteins that are secreted into the pharyngeal lumen to facilitate the transport of bacteria through the pharynx (Smit et al., 2008) . Expression of these phat genes requires the combinatorial activity of both PHA-4 and HLH-6. However, the activities of PHA-4 and HLH-6 do not fully account for gene expression in pharyngeal glands for three reasons. First, in addition to directly driving expression of the phat genes in all gland cells, HLH-6 also acts to specify the fates of a subset of the gland cells (the g2 cells), however the remaining gland cells are born and specified correctly indicating that additional factors are required for the specification of the remaining gland cells. Second, the expression of some gland-specific genes is HLH-6 independent, indicating that additional transcription factors are required for the gland-specific transcription program (Table 1) . Third, several of these gland expressed genes (both HLH-6 dependent and HLH-6 independent) are expressed in only a subset of the five gland cells, adding another level of complexity to their spatial regulation (Table 1) .
In this work we show that some of the gland-specific genes that are expressed independently of HLH-6 are under the control of a previously described cis-element called HRL3 (Hlh-6 Regulatory eLement 3), originally identified in the promoter of hlh-6 itself (Ghai and Gaudet, 2008) . Furthermore, we identify unique regulatory elements that are sufficient to restrict expression of the gland expressed genes, Y8A9A.2 and phat-5, to a subset of gland cells. We also find that nhr-48, a gene predicted to encode a nuclear hormone receptor, is required to confine Y8A9A.2 expression to a subset of glands. These findings suggest that while all gland cells have a common role in feeding and share many expressed genes, the individual gland subtypes may have specific function(s) apart from their collective roles.
Results

2.1.
Identification and regulation of additional gland expressed genes 2.1.1. Genes directly, indirectly, or partially dependent on hlh-6
The pharyngeal gland expressed genes that we previously described, which included six phat genes (and four additional genes, three similar to the PHATs), were all dependent on List of gland expressed genes whose expression patterns were verified. Dependence on HLH-6 for expression was determined in hlh-6 mutants. Functional PGM1 sites were identified by mutating predicted sites in transcriptional reporters. Gland expression is represented by reporter expression in the five gland cells: g1P, g1A (L&R), and g2 (L &R) (see Fig. 3A ). a From Smit et al. (2008) .
hlh-6 for gland expression (Smit et al., 2008) . We wanted to identify additional gland-expressed genes to determine if hlh-6 dependence is a characteristic of most or all gland-expressed genes. Fig. 1 ), all contained predicted PHA-4 binding sites, as expected. Their promoters (5 kb sequence upstream of ATG) were searched for any potential PGM1 (Phayngeal Gland Motif 1) sites (either CAnnTGnnYMAAY or CAnnTGnYMAAY), which we previously showed to be responsive to HLH-6 (Smit et al., 2008) . If no PGM1 sites were identified in the promoter region, introns were searched. Any potential PGM1 sites were mutated in transcriptional reporter constructs to test functionality. Among the 10 genes, only T05B4.13 had a PGM1 site that was required for expression. It is not surprising that T05B4.13 is dependent on a PGM1 site for expression because it encodes a ShK domain-containing protein that closely resembles the PHAT proteins, and expression of other phat genes relies on PGM1 for their expression (Smit et al., 2008) . Furthermore, T05B4.13 expression is completely eliminated in an hlh-6 null mutant background ( Fig. 1A,B ; Supplementary  Fig. 1 ), suggesting that T05B4.13 is part of the phat gene family and regulated by HLH-6.
The other nine gland-expressed genes that we examined lacked functional PGM1 sites. Expression of the B0280.7 reporter, nevertheless, was lost in an hlh-6 mutant background ( Fig. 1C,D; Supplementary Fig. 1 ). This suggests that HLH-6 is required for expression of B0280.7; however, since we were unable to identify any probable HLH-6 response elements, the regulation may be indirect or may use a response element that differs from the defined PGM1 consensus sequence. The expression of two additional gland genes, ZK596.1 and scl-3, is diminished in hlh-6 mutants (Fig. 1E ,F and Fig. 1G ,H; respectively), suggesting that expression of ZK596.1 and scl-3 is only partially dependent on hlh-6 (Supplementary Fig. 1 ). Since ZK596.1 and scl-3 lack functional PGM1 sites, the partial dependence on hlh-6 may be indirect, or through a PGM1 variant we have not identified. Four of the 10 gland-expressed genes, wrt-3, nas-12, Y8A9A.2, and Y76B12C.3, lacked PGM1 sites and their expression was unaltered in hlh-6 mutants ( Fig. 1I-N Supplementary  Fig. 1 , data not shown for Y8A9A.2), suggesting regulation by some other factor(s).
Genes dependent on the regulatory element HRL3
The expression of gland-expressed genes that is independent of HLH-6/PGM1 suggests that factor(s) in addition to HLH-6 are capable of driving gland expression. To identify cis-elements through which these other factors would act, we analyzed the promoters of nas-12 and Y8A9A.2. A series of 5' deletions were made in the promoter of nas-12 to identify potential regulatory regions required for gland expression. A minimal promoter fragment of 132 bp (À132 bp from the ATG, Fig. 2A ) was sufficient to drive expression in the glands. To identify sequences important for expression of this gene, comparison of this 132 bp sequence was performed with the comparable regions in closely related Caenorhabditis species (C. briggsae, C. brenneri, C. remanei and C. japonica), using the University of California Santa Cruz Genome Browser (www.genome.ucsc.edu). Alignment of these sequences identified four regions that are conserved across all five species, including a possible PHA-4 Binding Site (PBS) ( Fig. 2A,B) , of sequence TGTGTGC. This sequence differs from the previously defined PHA-4 consensus site, TRTTKRY Gaudet and Mango, 2002 ), yet matches a modified binding site identified by sequencing of fragments bound by PHA-4 in vivo (ChIP-seq) (Zhong et al., 2010) . Similarly, a TGTGTGC sequence shows weak pharyngeal enhancer activity in vivo, suggesting that this sequence is responsive to PHA-4 (Raharjo et al., 2010) and that this sequence in the nas-12 promoter may function as a PHA-4 response element.
To determine which of the other three conserved regions ( Fig. 2A ) may be required for expression from the minimal nas-12 promoter, additional deletions were examined. Deletion of the CR1 nas-12 (À118 bp, CR = conserved region) did not affect expression in the gland cells, however, deletion of both CR1 nas-12 and PBS nas-12 (-93 bp) resulted in a near complete loss of gland expression ( Fig. 2A) , consistent with the dependence on PBS of all other pharyngeal genes examined to date. To confirm this result, we mutated the PBS site alone (PBS nas-12 mut1, TGTGTGC ! GGATCCC Fig. 2A ,B) and found that this mutation completely abolished expression (n = 39).
During our analysis, we noted a similarity between the PHA-4 site in the nas-12 promoter and the PHA-4 site in the hlh-6 promoter. In the hlh-6 promoter, we previously found that sequence immediately 3' of the PHA-4 binding site was critical for expression in the glands (Ghai and Gaudet, 2008; Raharjo et al., 2010) . This result led to the identification of a distinct cis-acting element, partially overlapping the PHA-4 site, which was designated HRL3 (Hlh-6 Regulatory eLement 3). We demonstrated that HRL3 could function as a distinct enhancer when placed distal to a generic PHA-4 response element (Ghai and Gaudet, 2008) . Interestingly, the PHA-4 site in the nas-12 promoter PBS has a similar 3' sequence as that seen in the hlh-6 promoter. To determine if this HRL3-like flanking sequence was also required for gland expression in the nas-12 promoter, we mutated only the HRL3 sequence flanking the PBS nas-12 site (PBS nas-12 mut2, TGTGTGCT-CAGC ! TGTGTGCTTTGC, Fig. 2A ,B) and found that this mutation completely abolished expression in the gland cells (n = 43). Since the HRL3-like sequence in nas-12 is necessary for gland expression, we also tested if it is sufficient for gland expression, comparable to the PBS/HRL3 sequence from hlh-6. We found that enhancers that contain three tandem copies of the nas-12 PBS/HRL3 sequence upstream of a promoter-less GFP reporter activated expression specifically in the gland cells (Fig. 2C) , suggesting that the conserved element in the nas-12 promoter is in fact a functional HRL3 site. Thus, although nas-12 is not regulated by hlh-6, both hlh-6 and nas-12 likely are regulated by the same factor acting with PHA-4 through composite PBS/HRL3 sites.
We next asked if the other HLH-6-independent gland expressed genes are also dependent on an HRL3 sequence. We found a HRL3-like sequence in the promoter of the gene Y8A9A.2 (Fig. 2D) , which is predicted to encode a thrombospondin-like metalloprotein of unknown function that is expressed only in two of the five gland cells (Table 1) . To test if this site is a functional HRL3 site, we made separate mutations both to the PBS sequence (TGTTGGT ! CCTTGGT) and to the conserved HRL3 sequence 3' to the PBS site (TGTTGGTTTAGCT ! TGTTGGTTTTTTT). Both of these mutations abolished Y8A9A.2 reporter expression, confirming that this HRL3 site is necessary for expression (Fig. 2D , n = 37 and 32, respectively). Additionally, the promoters of several other HLH-6-independent genes (Table 1) were search for instances Fig. 1 -Dependence on hlh-6 of gland expressed genes. Expression of GFP gland transcriptional reporters in wild type (left) and hlh-6 mutants (right). T05B4.13 (A, B) and B0280.7 (C, D) reporters were completely inactive in hlh-6 mutants. ZK596.1 (E, F) and scl-3 (G, H) reporters were partially reduced by the loss of hlh-6 (see Supplementary Figure 1 ) while wrt-3 (I, J), nas-12 (K, L), and Y76B12C.3 (M, N) reporters were unchanged in hlh-6 mutants.
of potential HRL3 sites that were well conserved between multiple Caenorhabditis species. From this analysis a potential HRL3 site was identified in the promoter of Y76B12C.3; this sequence strongly matches the PBS/HRL3 sequences of hlh-6, nas-12 and Y8A9A.2, suggesting that it too may be directly regulated by the HRL3 factor. However, other genes that are indirectly regulated by HLH-6, through an unknown factor (wrt-3, B0280.7, ZK596.1 and scl-3), do not have any matching HRL3-like sites in their promoters or introns, suggesting that an additional factor(s) exists to regulate their expression.
Regulation of genes expressed in specific gland subtypes
Of the gland-expressed genes we have identified, a subset (Y8A9A.2, phat-5, gly-15 and F15D4.5) appears to be restricted to specific gland sub-types (Fig. 3) . Of these genes, at least two, Y8A9A.2 and phat-5, are activated by enhancers that normally function in all five glands -specifically, HRL3 and PGM1, respectively (Fig. 2C, Smit et al., 2008 ). These observations imply that Y8A9A.2 and phat-5 require additional factor(s) to restrict their expression to a subset of gland cells. Thus, we searched for additional element(s) or factor(s) that restrict expression of Y8A9A.2 and phat-5 to a subset of gland cells.
2.2.1. Identification of a regulatory element in the Y8A9A.2 promoter, that is both necessary and sufficient to repress expression in the g1a gland cells Y8A9A.2 was first identified as being gland sub-type-expressed based on mRNA in situ expression patterns (Kohara, 2001) . Expression was limited to the g1P and g2 gland cells (Fig. 3A) , with no expression visible in the g1A cells. We confirmed this expression pattern with a Y8A9A.2::GFP construct containing 196 bp of upstream promoter sequence (Fig. 3B-D,  4A ,B-E).
To identify cis-elements required for negative regulation in the g1A glands, the Y8A9A.2 minimal promoter sequence was aligned with the other Caenorhabditis species. A 67 bp region of well-conserved sequence was split into three blocks based on segments of high conservation (CR Y8A 1-3 - Fig. 4 ). Deletions that removed region 1 or regions 1 and 2 had no affect on expression of Y8A9A.2::GFP (Fig. 5A,B ; Table 2 ). However, when region 3 (with or without deletion of regions 1 and 2) was deleted from the minimal promoter, expression of the reporter was observed in all five gland cells in 73% of transgenic animals ( Fig. 5C,D ; Table 2 ). Therefore, region 3 functions to restrict expression of Y8A9A.2 to the g1p and g2 gland cells.
The central 12 bp of CR3 Y8A is completely conserved between Caenorhabditis species (Fig. 4E) , suggesting that this sequence might contain a site for a trans-acting factor. To identify candidate transcription factors that bind sites similar to this sequence, we searched UniProbe (www.the_brain.bwh. harvard.edu/uniprobe/), a database of known transcription factor binding sites, across multiple species. The highest scoring matches were all related mammalian Nuclear Hormone Receptor (NHR) half-sites (Fig. 4E) , including Retinoic Acid Receptor Alpha, Nuclear Receptor 2F2 and Estrogen-Related Receptor Alpha, all of which have a TGACCTTT consensus sequence, which is nearly identical to the TGACCATT sequence found within CR3 of Y8A9A.2.
To test if CR3 Y8A is the cis-element required to prevent expression in the g1A glands, the site was specifically mutated the site (GATCCATT,) in the Y8A9A.2 promoter. Interestingly, this mutation extended expression to the g1A gland cells in 77% of young larvae ( Fig. 5D ; Table 2 ). This result was confirmed by co-expressing Y8A9A.2(NHR mut )::GFP with the marker phat-1::wCherry, which is expressed in all gland cells; indeed these reporters had identical expression patterns, being co-expressed in all gland cells (Fig. 5E,F) . These data suggest that CR3 Y8A is required to repress expression of Y8A9A.2 in the g1A cells, thereby restricting expression to the g1P and g2 cells.
We next tested whether the NHR-like site of CR3 is sufficient for repression of expression in g1A cells. To test this, we employed enhancer constructs similar to those we have used previously (Ghai and Gaudet, 2008) . The '3x PGM1' enhancer is strongly and specifically expressed in all gland cells (100% n = 30, with some expression in a few neurons; Fig. 6A ; Table 2 ). The 3x NHR element has no activity on its own (Fig. 6B) , but when combined with PGM1 (in the '3x PGM1 + 3x NHR' enhancer construct) restricts expression to the g1P and g2 cells in 67% of transgenics (n = 70) ( Fig. 6C; Table 2 ), indicating that the CR3 Y8A NHR site is sufficient to repress expression in the g1A cells. Taken together, these data suggest that a potential NHR binding site in CR3 Y8A is both necessary and sufficient to repress expression in the g1A cells, allowing for Y8A9A.2 to be correctly restricted to the g1P and g2 cells.
NHR-48 is Required to Repress Expression in the g1A Cells of Y8A9A.2
We next wanted to identify a NHR that could potentially bind to the NHR site in CR3 Y8A . In C. elegans, there are approximately 284 predicted Nuclear Hormone Receptor genes. Of these, only 10% have been characterized, functioning in processes such as lipid and xenobiotic metabolism, molting, life span, and neural development (Antebi, 2006; Sluder and Maina, 2001; Taubert et al., 2010) . Only six NHRs have predicted or confirmed targets and binding sites. With the exception of daf-12, which is expressed in most tissues, including the pharynx (Snow and Larsen, 2000) , none of the well-characterized NHRs are expressed in the gland cells (Gissendanner et al., 2004; Miyabayashi et al., 1999) . However, in our search for new gland-specific genes described earlier, we identified two uncharacterized NHR genes, nhr-48 and nhr-60 (Supplementary Table 1 ) that had reported gland expression (Gissendanner et al., 2004) . When expressed in a nhr-60(ok1622) background, Y8A9A.2::GFP expression was unchanged (data not shown). However, in the nhr-48(ok178) background, Y8A9A.2::GFP expression was extended to the g1A cells, with 57% (n = 51) of nhr-48 mutants expressing Y8A9A.2 in all the gland cells ( Fig. 5G ; Table 2 ). We were able to rescue this misexpression in the g1A cells in nhr-48(ok178) mutants by introducing the fosmid WRM0623bH11, which contains a wild-type copy of the nhr-48 genomic locus (see Supplemental Fig. 2, Table 2 ). This misexpression of Y8A9A.2 in the g1a cells was similar to that observed when the NHR site was mutated directly, implying that NHR-48 acts through CR3 Y8A . Consistent with this hypothesis, a nhr-48::GFP reporter (a gift from Dr. Christopher Gissendanner, University of Louisiana) is preferentially expressed in g1A glands (61%, n = 62) ( Fig. 5H; Table 2 ).
A Conserved cis-Element in the Promoter of phat-5 is
Required to Repress Expression in the g2 Cells phat-5 is only expressed in the g1A gland cells, a pattern reciprocal to that of Y8A9A.2 (Fig. 3E , Smit et al., 2008) . We previously identified an 880 bp promoter that was sufficient to drive g1A gland expression of phat-5 ( Fig. 7A ; Table 2 , Smit et al., 2008) . To identify repressive cis-elements in the phat-5 promoter that repress expression in the g1P and g2 cells, we generated a smaller (304 bp) promoter fragment that still resulted in expression only in the g1A gland cells (Fig. 7A,B ; Table 2). Alignment of this minimal promoter with the corresponding regions from other Caenorhabditis genomes identified three conserved regions: CR1-3 phat-5 (Fig. 7B) . Deletion of both CR1 phat and CR2 phat extended expression of phat-5::GFP to the g2 (but not g1p) cells in 96% of transgenic animals (n = 47, Table 2) (Fig. 8B) . Furthermore, mutatation of CR1 phat (AAGATTCGAC) similarly extended expression to the g2 cells in 84% of animals (n = 38, Table 2 , Fig. 8C ), whereas mutation of CR2 phat-5 or CR3 phat-5 had no effect on expression elegans and other related Caenorhabditis species. Bold residues in E highlight the 12 bp conserved region of CR3 y8a , and the NHR-like site is underlined and boxed in red. Also included in (E) are alignments generated from Uniprobe. Mm = Mouse, Rara = Retinoic Acid Receptor Alpha, Ne2f2 = Nuclear Receptor 2f2, Esrra = Estrogen-Related Receptor Alpha. In all figures asterisks mark residues that are 100% conserved between all five species. (Fig. 8D,E) . These data suggest that while CR1 phat-5 is necessary for repressing phat-5 expression in the g2 cells, there must be an additional regulatory mechanism to block expression in the g1P cell.
CR1 phat is Sufficient to Repress Expression in the g2 Cells and the g1P Cell
Because CR1 phat is necessary to repress g2 expression of the phat-5 reporter, we next tested whether this sequence was also sufficient for repression in g2 cells. As before, we used combinatorial enhancer constructs to test this possibility. '3x CR1 phat ' alone is not sufficient to activate expression in any cells ( Fig. 6E; Table 2 ). '3x PGM1' is expressed in all gland cells, and as expected, addition of '3x CR1 phat-5 ' blocked expression in 83% (n = 54) of the g2 cells. Surprisingly, expression was also blocked in the g1P cells in these animals ( Fig. 6D; Table 2 ). This implies that the CR1 phat-5 sequence is necessary and sufficient to repress expression in the g2 cells, Table 2 for details.
and is sufficient but not necessary to repress expression in the g1P cells, at least in the context of the phat-5 promoter. One possible explanation is that additional sites present elsewhere in the minimal phat-5 promoter function redundantly with the CR1 phat-5 to repress expression in g1P.
To identify any potential trans-acting factors for CR1 phat-5 , the UniProbe database was searched with CR1 phat-5 (CGATAAATCAT). Two of the highest-scoring matches were murine Lef1 and Tcf7l2 (Fig. 8F) , members of the Lef/Tcf family of HMG (High Mobility Group) transcription factors (Behrens et al., 1996; Castrop et al., 1992; Milatovich et al., 1991) . Typically, Lef/Tcf factors act downstream of Wnt signaling, and in C. elegans the sole Lef/Tcf member is POP-1 (Herman, 2001; Lin et al., 1995; Siegfried and Kimble, 2002) . While the exact POP-1 binding site is not known, it is thought to bind a site similar to the Tcf/Lef sites reported here (Owraghi et al., 2010) . We examined phat-5 expression in a pop-1(q645) mutants, but found that there was no expression in the g2 (or g1P) cells (data not shown). Therefore we suspect that POP-1 is not the factor acting through CR1 phat-5 , however, the pop-1(q645) allele is hyopmorphic so we cannot fully reach this conclusion. Additionally, this factor may still be a nonLef/Tcf related HMG factor.
Discussion
Our previous work showed that hlh-6 is required for gene expression in pharyngeal glands, where it acts through the PGM1 motif (Smit et al., 2008) , though this work also suggested the presence of additional regulators acting in glands, as hlh-6 mutants still contain differentiated gland cells. Here, we have identified additional gland-expressed genes and find that transcriptional regulatory inputs other than HLH-6 are necessary for their regulation. We demonstrated that at least two hlh-6 independent gland genes, nas-12 and Y8A9A.2, require a cis-acting motif (HRL3), previously described based on its requirement for hlh-6 expression. Furthermore, some genes use yet other cis-elements and trans-acting factor(s) in addition to HLH-6. For example, B0280.7 is indirectly regulated by HLH-6 through an unidentified factor. Additionally, ZK596.1 and scl-3 are only partially dependent on HLH-6. It is possible that all gland genes are activated by the HRL3 factor (directly or indirectly), placing HRL3 on the top of the gland regulatory hierarchy. However, there is at least one gland gene, wrt-3, whose expression cannot at present be accounted for by either hlh-6/PGM1 or HRL3.
While a number of independent transcription programs bring about expression within the gland cells of the pharynx, additional mechanisms are employed to further refine expression, including restricting some genes to subsets of those gland cells. We have identified negative cis-elements that act to repress expression in subsets of gland cells. NHR-48 acts through a NHR site in the Y8A9A.2 promoter to represses expression in the g1A cell. phat-5 is expressed in the reciprocal subset of gland cells, where an unknown factor (possibly an HMG protein) acts through the CR1 phat site in the phat-5 promoter to repress expression in g1P and g2 (although it acts redundantly in the latter). Typically, NHRs function as ligand-activated transcription factors, regulating gene expression by binding to Hormone Response Elements (HREs) in promoters of target genes (Olefsky, 2001) . Upon binding of an appropriate ligand, the NHR enters the nucleus, where it will complex with co-activators or co-repressors and binds directly to the HRE (Evans, 1988; Kumar and Thompson, 1999) . Generally, HREs are composed of two inverted repeats and bind either homo-or heterodimers of NHRs. However, in some cases NHRs have been known to bind HRE half-sites as monomers (Mangelsdorf and Evans, 1995; Umesono et al., 1991) . Here, it appears that the potential NHR-48 binding site in the Y8A9A.2 promoter (TGACCATT) may be an HRE half-site, as most C. elegans NHR transcription factors are known to bind to similar HRE half-sites (Ao et al., 2004 In C. elegans and other nematodes there has been a massive expansion of NHRs (Maglich et al., 2001) . It is hypothesized that > 90% of these NHR proteins are so-called 'divergent NHRs' that have gone through significant diversification and may have nematode-specific or ligand-independent functions (Robinson-Rechavi et al., 2005; Taubert et al., 2010) . NHR-8 and DAF-12 are two NHRs that are closely related to NHR-48 (based off sequence homology from WormBase), and both have a DNA binding domain and ligand binding domain present (Supplemental Fig. 3) . Analysis of the NHR-48 protein sequence identified a well-conserved DNA-binding domain; however, no clear ligand-binding domain is present ( Supplemental  Fig. 3) . Additionally, NHR-48 does not show conservation outside the DNA-binding domain compared to both NHR-8 and DAF-12 (Supplemental Fig. 3) , as well as its Drosophila homolog, Hr96 (Hormone Receptor 96), or human homolog, VD3R (Vitamin D3 Receptor) (data not shown). These observations suggest a possible ligand-independent function for nhr-48. (C) 3x PGM1 combined with 3x NHR (hexagons), to create '3x PGM1 + 3x NHR', was sufficient to repress g1A gland expression normally driven by 3x PGM1 (asterisk). (D) Three copies of the CR1 phat site (pentagons) in front of GFP (3x CR1) did not drive any expression. (E) '3x PGM1' combined with '3x CR1 phat-5 ' '3x PGM1 + 3x CR1 phat-5 ' was sufficient to repress g2 and g1P gland expression normally driven by 3x PGM1 (asterisk). Refer to Table 2 and text for details.
We previously demonstrated that one critical function of the gland cells is to secrete PHAT proteins at various positions along the pharyngeal lumen, as the duct projections of the individual subtypes terminate at different positions along the pharyngeal lumen ( Fig. 3A ; Smit et al., 2008 ). An unresolved issue is the function of the gland subtype-expressed genes described here. For example, why is Y8A9A.2 expressed in the g1P and g2 cells, and excluded from the g1A cells? Y8A9A.2 is characterized as a zinc metalloprotein with a thrombospondin-like domain. Thrombospondins are glycoproteins typically expressed in the extracellular matrix and function to regulate cell-cell interactions (Bork and Beckmann, 1993; Feinstein et al., 1999) . This could be important for migration of the M1 axon, which is in contact with the g1P projection, and preliminary analyses suggest that g1P is required for normal growth of the M1 axon (Osama Refai and Jeb Gaudet, unpublished) , though it is unclear whether Y8A9A.2 plays a role here. Another possible function for Y8A9A.2 could be in mediating cell-cell interactions between g2/g1P and pharyngeal muscle cells in the terminal bulb.
Why is phat-5 expressed in the g1a cells and not the other gland cells? PHAT-5 contains no differences in functional protein domains or motifs when compared to the other PHAT proteins (using the PFAM database), suggesting nothing biochemically or functionally novel about PHAT-5 that would hint at any g1A-specific function. One possible explanation is that phat-5 does not have a g1A specific role. Rather, there may be a requirement for the g1A cells to produce an overall greater quantity of PHAT protein localized to the metacarpus and isthmus due to the g1A cells having to cover the large 'middle ground' between the PHAT-secreting g1P and g2 cells.
The 'sub-type identity' of the gland cells is not only at the level of anatomical or morphological differences, but also at the level of gene expression. Sub-type specific developmental programs are in some way connected to sub-type specific morphology and function, though the unique properties of the different glands are not fully understood. And while the gland cells might not have radically different functions, these small differences in genes expression patterns, morphology, and position along the lumen, could lead to more profound specializations of the gland over evolutionary history. Understanding how gland expressed genes are differentially regulated, how the regulatory mechanisms may differ, and the functional significance of individual subtypes will help elucidate what we know about the development of more complex organs.
4.
Materials and methods
Nematode handling conditions
Standard conditions were used as previously described (Brenner, 1974) . The following strains of C. elegans were used: N2 (wild-type); GD211: rol-6(e187) hlh-6(tm299) unc-4(e120), AA107: nhr-48(ok176), RB1425: nhr-60(ok1622), JK2689: pop-1(q645) dpy-5(e61) I/hT2[bli-4(e937) let-?(q782) qIs48] (I;III). AA107 and RB1425 were each out-crossed five times prior to general use.
Construction of plasmids and reporters
All promoter constructs were made as previously described in Raharjo and Gaudet (2007) by cloning promoter fragments from genomic DNA (or previously cloned constructs) into the GFP encoding vector, pPD95.77 or YFP encoding pPD95.77-YFP (gifts from A. Fire, Stanford University). Promoter mutations were generated by PCR based site-directed mutagenesis (Ho et al., 1989) . A list of oligo used to generate reporter construct (aside from those described in Smit et al., 2008) Caenorhabditis species. C. japonica was excluded from the analysis because it had very poor conservation with other species throughout the phat-5 promoter. Asterisks mark 100% match between residues. See Table 2 for details.
